Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Florence

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Neurology|April 1, 1989
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapyM H Brooke, G M Fenichel, R C Griggs, et al.
Chemmedchem|August 23, 2014
Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Spine|July 2, 2019
Clinical Efficacy of Frameless Stereotactic Radiosurgery in the Management of Spinal Metastases From Thyroid CarcinomaOmid Hariri, Ariel Takayanagi, Jonathan Lischalk, et al.
World Neurosurgery|July 12, 2023
Lumbar Spinal Canal Segmentation in Cases with Lumbar Stenosis Using Deep-U-Net EnsemblesAzim N Laiwalla, Anshul Ratnaparkhi, David Zarrin, et al.
Crystal Growth & Design|February 7, 2023
Machine Learning-Derived Correlations for Scale-Up and Technology Transfer of Primary Nucleation KineticsStephanie Yerdelen, Yihui Yang, Justin L Quon, et al.
The New England Journal of Medicine|June 15, 1989
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophyJ R Mendell, R T Moxley, R C Griggs, et al.
Muscle & Nerve|December 1, 1990
Randomized, double-blind trial of mazindol in Duchenne dystrophyR C Griggs, R T Moxley, J R Mendell, et al.
Muscle & Nerve|November 1, 1988
Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin EG M Fenichel, M H Brooke, R C Griggs, et al.
Chemmedchem|June 11, 2016
Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei InhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Molecular Pharmaceutics|May 12, 2020
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative TechnologiesLuke Schenck, Deniz Erdemir, Lindsey Saunders Gorka, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Neurology|April 1, 1989
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapyM H Brooke, G M Fenichel, R C Griggs, et al.
Chemmedchem|August 23, 2014
Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Spine|July 2, 2019
Clinical Efficacy of Frameless Stereotactic Radiosurgery in the Management of Spinal Metastases From Thyroid CarcinomaOmid Hariri, Ariel Takayanagi, Jonathan Lischalk, et al.
World Neurosurgery|July 12, 2023
Lumbar Spinal Canal Segmentation in Cases with Lumbar Stenosis Using Deep-U-Net EnsemblesAzim N Laiwalla, Anshul Ratnaparkhi, David Zarrin, et al.
Crystal Growth & Design|February 7, 2023
Machine Learning-Derived Correlations for Scale-Up and Technology Transfer of Primary Nucleation KineticsStephanie Yerdelen, Yihui Yang, Justin L Quon, et al.
The New England Journal of Medicine|June 15, 1989
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophyJ R Mendell, R T Moxley, R C Griggs, et al.
Muscle & Nerve|December 1, 1990
Randomized, double-blind trial of mazindol in Duchenne dystrophyR C Griggs, R T Moxley, J R Mendell, et al.
Muscle & Nerve|November 1, 1988
Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin EG M Fenichel, M H Brooke, R C Griggs, et al.
Chemmedchem|June 11, 2016
Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei InhibitorsGordon J Florence, Andrew L Fraser, Eoin R Gould, et al.
Molecular Pharmaceutics|May 12, 2020
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative TechnologiesLuke Schenck, Deniz Erdemir, Lindsey Saunders Gorka, et al.
Pageof 16